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A B S T R A C T
Purpose: There is a need for a seizure-detection system that can be used long-term and in home situations
for early intervention and prevention of seizure related side effects including SUDEP (sudden unexpected
death in epileptic patients). The gold standard for monitoring epileptic seizures involves video/EEG
(electro-encephalography), which is uncomfortable for the patient, as EEG electrodes are attached to the
scalp. EEG analysis is also labour-intensive and has yet to be automated and adapted for real-time
monitoring. It is therefore usually performed in a hospital setting, for a few days at the most. The goal of
this article is to provide an overview of body signals that can be measured, along with corresponding
methods, state-of-art research, and commercially available systems, as well as to stress the importance of
a good detection system.
Method: Narrative literature review.
Results: A range of body signals can be monitored for the purpose of seizure detection. It is particularly
interesting to include monitoring of autonomic dysfunction, as this may be an important patho-
physiological mechanism of SUDEP, and of movement, as many seizures have a motor component.
Conclusion: The most effective seizure detection systems are multimodal. Such systems should also be
comfortable and low-power. The body signals and modalities on which a system is based should take
account of the user’s seizure types and personal preferences.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
Seizure
jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Epilepsy is the most common serious neurological condition,
affecting almost 60 million people (close to 1% of the world
population) and 2.5 million new cases each year. Its prevalence has
a bimodal distribution with peaks in infancy and older age (65+).
For 25–30% of all patients, no combination of standard therapy
(medication or surgery) can control their seizures. These patients
are said to suffer from refractory or intractable epilepsy.1–5* Corresponding author. Tel.: +32 3 821 51 40.
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1059-1311/$ – see front matter  2013 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2013.02.012Compared to a normal population, the mortality risk for
patients with epilepsy is elevated by a factor of two to three, with a
mean annual mortality rate of 1%. Epilepsy-related deaths can be
divided into four categories. First, deaths resulting from the
underlying cause of epilepsy, neurological or anatomical (e.g. brain
tumour). Second, deaths caused directly by epilepsy itself (status
epilepticus or SE, drowning, burning, trafﬁc and other traumatic
accidents) or its treatment. Third, deaths due to co-morbidities,
including depression leading to suicide, co-existent neurologic
compromise, and respiratory tract infection or pneumonia after
repetitive aspiration during seizures. Fourth, deaths of unknown
cause, called sudden unexpected death in epilepsy (SUDEP).6–8
SUDEP is deﬁned as a sudden, unexpected, witnessed or
unwitnessed, non-traumatic and non-drowning death, occurring
in benign circumstances, in an individual with epilepsy, with or
without evidence for a seizure (with onset within the preceding
hour) and excluding documented SE (seizure duration 30 min orvier Ltd. All rights reserved.
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examination does not reveal a cause of death.9
Three of these most common causes of death could possibly be
prevented through seizure detection. SE contributes to up to 16% of
deaths, traumatic accidents comprise up to 30% and SUDEP
accounts for up to 38%.1,10
Of the limited number (7–38%) of witnessed incidents of SUDEP,
33–100% were preceded by seizures (in most cases, convulsive). In
the unwitnessed incidents of SUDEP, it is not always clear whether
a seizure took place, although almost 90% involve evidence of
tongue biting, incontinence or disrupted environment, strongly
suggesting a recent convulsive seizure (but not excluding other
explanations).11–13
This article is based on our own work, the difﬁculties that have
been encountered by other research teams in the ﬁeld and the
many requests from parents and patients for a robust seizure-
detection system, and inspired by our observation that information
on this topic is difﬁcult to obtain. Even though non-EEG (electro-
encephalography) systems have appeared on the market recently,
experience with these systems is still limited.4,14–18 The goal of this
article is to provide healthcare professionals, engineers, as well as
interested patients with an overview of body signals that can be
measured, along with the corresponding methods of measure-
ment, state-of-art research and available systems. The article also
stresses the importance of a good system for early intervention,
reassurance of patient and environment, and prevention of SUDEP.
2. SUDEP
2.1. Risk factors and triggers
It has been suggested that SUDEP is caused by the co-existence
of several predisposing (inter-ictal) and triggering (peri-ictal)
factors. The former are known as risk factors and the latter as
patho-physiological mechanisms or direct causes. Knowledge of
the different risk factors could provide clues to possible patho-
physiological mechanisms. Likewise, understanding the mecha-
nisms may lead to the identiﬁcation of previously unrecognised
risk factors that could possibly be amenable to correction, thus
preventing SUDEP.8,19
Cardiac, respiratory and other autonomic dysfunctions have
been thoroughly investigated and proposed as patho-physiological
mechanisms for SUDEP. These dysfunctions result in decreased
cerebral oxygen supply and electro-cerebral shutdown. In other
words, inhibition of brain activity can be both a cause (seizure) and
a response.20
Risk factors that have been consistently identiﬁed include
epilepsy onset at young age, long duration of epilepsy, generalised
tonic–clonic seizures (GTCS), partial seizures (symptomatic
epilepsy) and polytherapy.21 Furthermore, many risk factors
constitute a risk due to their negative effects on the patho-
physiological mechanisms. For example, young people are known
to have a higher baseline vagal tone.22 In many cases, GTCS present
with tachycardia and tachypnoea.23,24 Partial seizures inﬂuence
the cardiopulmonary instability: ictal asystole and apnoea or
hypoventilation can occur in temporal lobe seizures, while ictal
tachycardia and irregular breathing often occur in hypermotor
frontal lobe seizures.25–27 Polytherapy can lead to cardiac and
respiratory dysfunction.28 In other words, it is particularly
interesting to include methods for monitoring cardiac, respiratory
and other autonomic body signals in detection systems.
2.2. Prevention
Because we are far from having a perfect method for predicting
seizures, let alone SUDEP, supervision is one of the key measures inaddition to control over risk factors. In one large case–control
study, supervision was associated with a substantial decrease in
the risk for SUDEP.11 Supervision might thus prevent SUDEP both
by detecting seizures and by monitoring SUDEP risk factors or
patho-physiological mechanisms, depending upon the methods
used (Section 4).
Possible actions by the caregiver after an alert include enabling
a proper position (from prone or supine to recovery); stimulating
the patient by rolling over or similar means (passive muscle
movement); cardio-pulmonary resuscitation and deﬁbrillation;
administrating medication or oxygen; clearing the airway;
protecting against injuries; and seeking help if needed. Supervision
also allows the caregiver to reassure and calm down the patient, to
maintain a vigil in the post-ictal phase and to clean the bed in case
of vomiting or incontinence.
3. Seizure detection
3.1. Seizure detection in general
The gold standard for monitoring epileptic seizures involves
video/EEG (electro-encephalography), which is uncomfortable for
the patient, as EEG electrodes are attached to the scalp. EEG
analysis is also labour-intensive and has yet to be automated or
adapted for real-time monitoring. It is therefore usually performed
in a hospital setting, for a few days at the most, and it is generally
used to conﬁrm the diagnosis of epilepsy instead of for objectively
quantifying seizure frequency or warning for potential SUDEP.
The interest in ambulant systems originates from the need to
monitor patients over extensive periods (weeks to months) and in
the natural home and outdoor environment (domiciliary and
residential settings).29 Long-term home monitoring might also
reduce costs by eliminating the need for hospital admission and
clinical observation.
Detecting seizures makes it possible to alert the caregiver, who
can take action, as described in Section 2.2. Generating an objective
log of the number, order, duration, affected body part and type of
seizures can inform the neurologist and help to optimise
treatment. Objective seizure logs could signiﬁcantly enhance the
somewhat unreliable patient-diary technique, which is subjective
and can be inﬂuenced by peri-ictally affected consciousness or
memory. One limitation of non-EEG seizure detection is that it
cannot provide retroactive veriﬁcation (by video/EEG) for events
that are logged as seizures.30
It should be made possible to adjust seizure alerts according to
the user’s personal preferences. Some parents might want to be
informed of every seizure, in order to reassure their child, while
institutions might request this information in order to comply with
insurance requirements. Other parents might not want to wake the
patient unnecessarily, and also hospital caregivers might prefer to
be informed only in the event of life-threatening seizures that
could signal near-SUDEP events and require immediate action. In
other words, an ideal system should be customised to seizure type,
as well as to seizure severity and quality of life.
Another factor to consider is which events need detection. One
common difﬁculty involves distinguishing epileptic seizures from
non-epileptic events (e.g. syncope, hypoglycaemic seizures in
diabetes, psychogenic non-epileptic seizures or pseudo-seizures),
life-threatening events (e.g. suffocation) and sleep-related dis-
orders (e.g. restless-leg syndrome, periodic limb movement
disorder, somnambulism, pavor nocturnus). However the relative
need for differential diagnosis is unclear. Because non-epileptic
events might also need care, similar safety protocols should be
administered.31 Furthermore, many patients have overlapping
disorders. For example, a third of all patients with nocturnal frontal
lobe seizures (NFLS) have a history of somnambulism, pavor
A. Van de Vel et al. / Seizure 22 (2013) 345–355 347nocturnus, rhythmic movement disorder and enuresis.32 On the
other hand, detecting ‘normal’ sleep-related movement or
vocalisations (e.g. nocturnal leg cramps, hypnic jerks, somniloquy)
might be redundant.
Monitoring during the day and when the patient is awake is
useful primarily for (young) adults. It is important when the
patient is alone, and allows for emergency care in case of drowning,
burning, trafﬁc and other traumatic accidents. One advantage of
daytime monitoring is that false alarms are less problematic and
can be turned off by the patient. On the other hand, detection
during sleep might be easier, as patients remain at the same
location within the detection range, since there is less noise from
voluntary movements and because convulsions occur in a
relatively controlled, reproducible manner. It is also more
important because of the reduction or lack of supervision, as
subjective elements that precede seizures (auras that allow
patients to foresee them) are unavailable and since some types
(particularly frontal lobe seizures)33 occur more often at night.
3.2. Intracerebral seizure detection
The main reasons why many studies focus on the early
detection or prediction of seizures using EEG (cortical or
intracranial) are obviously that epilepsy is a neurological disease
and that the ultimate purpose should be to prevent damage to the
brain by preventing seizures.
Electrographic seizures can already start before and propagate
to the clinically observable seizure, thus allowing the prediction
and possible prevention of clinical seizures or SUDEP (Fig. 1).
Automated EEG analysis could also allow predicting/detecting
seizures that remain sub-clinical or those for which clinical
expression is very subtle (e.g. absence seizures).
In addition to the risks of implanting intracranial systems and
the discomfort of head-attached devices, they raise a number of
other questions as well.
Does EEG detect all seizures? Some nocturnal seizures produce
subtle or no ictal EEG patterns during scalp recording, or their EEG
patterns may be obscured by excessive muscle artefacts. In fact,
certain forms of epilepsy (in which seizures occur almost
exclusively at night, including NFLS, where ictal EEG ﬁndings
are visible in only half of all cases)34 were not deﬁnitively
recognised as epileptic until the past 20–25 years.
Should EEG recordings be combined with physiological sources
as a standard form, given that the difﬁculty of detecting seizures is
exacerbated by contamination of EEG recordings with environ-
mental and biological artefacts?35Fig. 1. EEG sample of a seizure. Prediction can lead to prevention and early detection
to abortion of seizures.Could a seizure indeed be aborted through stimulation after the
onset of electrographic seizure activity, or has the brain already
passed the ‘point of no return’, to a state that will inevitably
progress into a clinical seizure manifestation?36 In other words,
how important is the latency period between the onset and
detection of electrographic seizures for allowing alarming and
action?
Do sub-clinical events require action at all? Who would beneﬁt
from preventive measures? Which actions should be taken and
when, both for preventing seizures and for preventing SUDEP?
3.3. Extracerebral or non-EEG seizure detection
Most engineers and neuroscientists focus on the link between
brain and epilepsy and not on the link between brain and body.
Extracerebral body signals are under cortical control and altered by
seizures as well, thus providing indirect but valuable information
about the state of the brain.30
Given that no ideal intracerebral devices are yet available
(automated detection and predictability of seizures have been
studied since the 1970s)36 and considering the many advances of
non-EEG seizure detection described below, it is surprising that
such devices are not mentioned more often in strategies for
epilepsy and preventing SUDEP.
First, regardless of their value, scientiﬁc advances may not
translate into improved care unless the devices are broadly
accessible. Extracerebral (or, more speciﬁcally, non-EEG devices)
are more widely applicable than intracranial devices are, as they
are not invasive and can, if contactless, even be non-obtrusive.30 In
other medical conditions, many devices for physiological signs (e.g.
for sleep disorders) and movement detection (e.g. for Parkinson
and fall detection) are already on the market, thus allowing the
transfer of knowledge. Non-EEG body signals might be less
complex.30 They might therefore allow smaller and less expensive
devices that use less power for automated analysis. Finally, non-
EEG devices could immediately be tested on human subjects.
Similar to coupling intracerebral detection to a preventive
or aborting action (Fig. 1), extracerebral or, more speciﬁcally,
non-EEG devices could include responsive stimulation of
heart, respiration or muscles (including diaphragmatic pacing),
administration of medication or oxygen or (less obviously) the
inﬂation of an ‘airbag’ to prevent injury. The latter has been tested
in the context of hip protection in order to prevent fall-related
injuries in the elderly.37 So strategies for epilepsy and preventing
SUDEP should not focus solely on ‘cure’ (if preventing or aborting
seizures can be considered a cure) but also on ‘care’ (disease
control) as part of the overall treatment plan.
4. Detection systems
4.1. Slow progression
Despite the plea for additional research focusing on non-EEG
detection devices for epileptic seizures, the ﬁeld is moving slowly,
and there is no clear overview of the devices that are on the market.
The obtrusiveness and excessive false alarms associated with these
devices often make patients reluctant to use them. Moreover,
many commercial systems detect primarily intense, long and
repetitive movements in general, and there is apparently no
scientiﬁc proof or information from clinical trials to provide users
with reliable information on their efﬁcacy.
Perhaps the greatest difﬁculty to overcome, and one reason why
companies might be reluctant to invest, involves the necessity of
customising the devices to the patient’s seizures (supervised
learning or patient-speciﬁc training) and the user’s personal
preferences (Section 3.1).
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Seizures may result (ictally, post-ictally or peri-ictally) in a
sudden alteration of sensation, motor activity or behaviour, psyche
(consciousness, responsiveness, post-ictal dysnomia), vocalisa-
tions or autonomic signs.
A signiﬁcant number of seizures is characterised by motor
symptoms,38 and partial seizures often show motor phenomena in
the early stages.30,39 Autonomic changes might even occur pre-
ictally,26 and ictal cardio-respiratory events appear to play a
crucial role in the context of SUDEP (before or without seizure
occurrence). For these reasons, non-EEG detection focuses on one
or a combination of these signals.
The following sections provide an overview of various detection
methods. Detection by metabolic (including hormonal) or tissue
stress biomarkers is not listed, as such devices are usually invasive.
It also provides a description of human studies (published recently
or in the past) involving non-EEG seizure-detection methods. The
discussed studies include development of a detection device, as
well as seizure algorithms and their results (Table 1).
4.3. Detecting cardiovascular changes
4.3.1. Electrocardiography (ECG)
Persistent heart rate (HR) elevations after exercise, decreased
heart rate variability (HRV, changes in the heart’s beat-to-beat
interval reﬂecting autonomic nervous system activation) and
cardiac repolarisation abnormalities are established predictors of
sudden cardiac death in other medical conditions or in healthy
populations.24
One-lead ECG recording allows detecting HR, HRV and ECG
morphology. As mentioned in Section 2.1, seizure-related HR
changes commonly occur, and they are more pronounced with
generalised tonic–clonic (GTCS), hypermotor frontal lobe and
temporal lobe (TLS) seizures. Such events subsequently increase
the risk of SUDEP. Ponnusamy and colleagues observed HRV
differences (high sympathetic and low vagal tone) in TLS, as
compared to psychogenic non-epileptic seizures.40 An example of
a change in ECG morphology is the QT interval shortening in GTCS,
found by Surges and colleagues.24
Challenges include the use of continuous ECG for distinguishing
arousal from sleep, standing from reclining and exercises (e.g.
climbing stairs) from seizures. The combination with a chest
accelerometer (ACM, Section 4.6.3) to determine position might
already be a ﬁrst step towards a possible solution.
A team from the Netherlands and Belgium and the partner-
ship between Holst Centre/imec and Hobo Heeze BV are
working to develop a system that is attached to the chest and
arm, which uses ECG for seizure detection. Published results and
more information are mentioned in Tables 1 and 2.4,41 Table 2
further mentions that the commercially available bed-mounted
seizure-detection system Emﬁt (Finnish company Emﬁt Ltd) can
detect the heartbeat by monitoring movement. This information
was taken from its website, no publication could be found. In
addition, the AspireSR system (US company Cyberonics, Inc.)
uses ECG-based seizure detection and is currently undergoing a
clinical trial.
4.3.2. Blood pressure
Blood pressure measurements can be performed by ﬁnger
plethysmography (or peripheral arterial tonometry, used for
recognising arousals), which is included in pulse oximeters
(Section 4.4). This technique investigates changes in autonomic
activity, and it can detect irregular heartbeat, pulse wave
amplitude and pulse transit time. The latter is inversely correlated
with blood pressure.424.4. Detecting respiration changes
Respiration is frequently altered during seizures, and monitor-
ing is also important in preventing SUDEP, not only for monitoring
breathing and apnoea, but for detecting sighs, yawns and arousal.
Low arousability is a possible sign of near-SUDEP, and two
important mechanisms involved in auto-resuscitation are arousal
and gasping.43,44 Numerous methods exist for monitoring respira-
tion, including the sensing of airﬂow temperature, pressure or
velocity; chest movement or volume changes; transcutaneous
blood-oxygen concentration or partial pressure; respiratory gases
oxygen or carbon dioxide concentration; and transcutaneous audio
or vibration signals resulting from breathing turbulence in the
larynx.
A thermocouple or thermistor placed below the nose senses
airﬂow temperature, a mask covering the nose and mouth senses
airﬂow pressure and a pneumotachography mask senses airﬂow
pressure or velocity. Although these devices are in common use,
they are associated with several disadvantages, including their
discomfort and inﬂuence on breathing.45
Sensing chest and abdominal wall movement in order to
measure respiratory rate/depth/effort is often performed by
measuring volume differences between the upper and lower chest
using two straps (respiratory inductance plethysmography, or
RIP),45 two electrodes (impedance pneumography)23 or magnet-
ometers,45 although it can also be performed using a single EMG
(electromyography, on diaphragm or intercostals muscles) or ACM
sensor (on chest or bed), and through remote measurement using
video or microwaves (Section 4.6). One disadvantage is that
respiratory movements can continue when there is already
apnoea. As mentioned in Table 2, the commercially available
bed-mounted seizure-detection systems Ep-It P139 (UK company
Alert-It) and Emﬁt (Emﬁt Ltd) can detect respiration changes by
monitoring movement. This information was again taken from
their websites, no publications could be found.
A pulse oximeter is a clamp attached to ear lobe or ﬁngertip
(which could be integrated into a ring). For babies, it can be
integrated into a foot strap or body sticker. It consists of a
saturometer (which uses infrared waves to sense blood-oxygen
concentration) and a plethysmograph (which measures changes in
volume within an organ, resulting from ﬂuctuations in the amount
of blood, as described in Section 4.3.2, or of air, as described in
reference to RIP). Oximetry is important, as it can identify rises in
blood pressure due to airway blockage (e.g. because of prone
position), despite continuing respiratory movements. The complex
interaction between brain, heart and respiration makes data on
oxygenation crucial in addition to information on respiration and
ECG.20,44
Electrodes that sense the transcutaneous partial pressure of
oxygen can detect respiration abnormalities faster and with fewer
false positives than saturometers produce. Poets and colleagues
have searched for possible mechanisms of Sudden Infant Death
Syndrome by measuring different respiration parameters. In this
study, electrodes were combined with pulse oximetry and chest-
movement detection, with the following ﬁndings: decreased
pressure without decreased saturation indicates changes in skin
perfusion, but not arterial hypoxaemia; decreases in both pressure
and saturation accompanied by tachycardia and slower, irregular
or absent respiration indicates an epileptic seizure; and decreases
in both pressure and saturation, preceded by increased amplitude
and irregular breathing movement (often combined with tachy-
cardia and massive body movements) indicates suffocation.44
Oxygraphy and capnography monitor the concentration (using
infrared waves, as in pulse oximetry) or partial pressure (using
electrodes, as above) of oxygen and carbon dioxide in respiratory
gases.46
Table 1
Human studies involving non-EEG seizure detection methods, including development of a device, as well as algorithms and their results. Below the bold line: articles on seizure alarm systems that are commercially available or
under clinical trial investigation, further discussed in Table 2. 2r = secondarily generalised, A=automotor seizure, ACM=accelerometer, C = clonic seizure, CPS= complex partial seizure, ECG=electrocardiography,
EDA=electrodermal activity, EEG=electro-encephalography, EMG=electromyography, FDR= false detection rate, FLS= frontal lobe seizures, (G)TC(S) = (generalised) tonic–clonic seizure, gyro =gyroscope, h =hours,
H=hyperkinetic/hypermotor seizure, HR=heart rate, IR = infrared wave, M=myoclonic seizure, magneto=magnetometer, mS=microsiemens, NPV=negative predictive value, PPV=positive predictive value, s = seconds,
SIDS= sudden infant death syndrome, SPS= simple partial (motor) seizure, T = tonic seizure, TLS= temporal lobe seizure, V=versive seizure, w/ =with.
Article Team location Detection method(s) Test subjects Seizures Real time (alarm) Contact (-less) Results
Becq et al.38 France ACM+magneto 2 patients 46 Yes Attached to torso/wrist Sensitivity 90%, FDR per night 0.7
Conradsen et al.60 Denmark ACM+gyro +EMG
(integrated
magneto not used)
10 healthy adults,
1 adult patient
Simulated M/V/TC,
1 real TC
No Sensor suit + electrodes
attached to belly/limbs
For different combinations of methods: see
article, best results when combining all three:
sensitivity 100%, FDR per hour 0, mean latency
0.75 s
Cuppens et al.54 Belgium Video 3 paediatric patients 14 M No Contactless Sensitivity>75%, PPV>85%
Dalton et al.2 US/Ireland ACM 5 adult patients 21 M, C No Attached to limbs Sensitivity 91%, speciﬁcity 84%, 50 false
positives (during day)
de Bruijne et al.67 Netherlands Audio 17 patients 95 No Contactless Sound observed in 61/95 seizures, 78 real and
175 simulated sounds studied, average
sensitivity 95–98%, speciﬁcity 72–97%, PPV
2–40% depending on sound type
Jallon61 France ACM 2 patients 46 Yes Attached to torso/wrist Sensitivity 88–89%, false alarms 25–45%
Karayiannis et al.55 US Video 54 infant patients M/C No Contactless Sensitivity and speciﬁcity>90%
Nijssen et al.62 Netherlands ACM 36 patients
(18 with seizures)
27T No Attached to arm Sensitivity 80% (5 missed e.g. because
movement was blocked), PPV 35% (42% of the
false alarms being M or C)
Nijssen et al.63 Netherlands ACM 15 patients for
training, 21 for
testing
29M for training,
35 for testing
No Attached to arms Sensitivity 80%, PPV 16% (148 false positives
during 3.6h, amongst which also C and T)
Poh et al.49 US EDA+ACM 80 paediatric
patients (7 with
seizures)
16 GTCS No Wristband with electrodes Sensitivity 94% (15/16), FDR per 24h 0.74 (130
false alarms, mainly during day)
Re´mi et al.50 Germany/
Portugal
Video 17 patients 10 H (FLS) +10 A (TLS) No Attached IR reﬂectors Sensibility for H 80.8%
Schulc et al.64 Austria ACM 20 adult patients
(3w/seizures)
4 GTCS Yes Attached to arm Sensitivity 100%, speciﬁcity 88%, PPV 75%
Van de Vel et al.65 Belgium ACM 7 paediatric patients 51 H of which
2 per patient used
No Attached to limbs Sensitivity 95.71%, PPV 57.84%
Beniczky et al.14 Denmark ACM 73 paediatric and
adult patients
(20w/seizures)
39 GTCS Yes Bracelet Sensitivity 89.7% (35/39), mean latency 55 s,
FDR per day 0.2 (40, all during day-time tasks)
Carlson et al.15 US Audio 64 paediatric and
adult patients
8 TC Yes Between bed and matrass Sensitivity 63% (5 detected), speciﬁcity 90%,
NPV 99%, PPV 3.3% (269 false positives during
1528h)
Conradsen et al.58 Denmark EMG 5 patients (2 with
seizures)
7 GTCS Yes Electrodes attached to leg Mean sensitivity 57% (4/7), latency 25 s, FDR per
hour 0.003 (1 false positive)
Fulton et al.16 US Audio (and body
pressure)
27 paediatric patients
(15w/seizures)
9 TC+8 2r TC+10 CPS+
2 SPS+40M, T, M+T=69
Yes Between bed and matrass MP5: detection rate 4.3% (1/23: a TC), ST-2:
2.2% (1/46: a CPS)
Kramer et al.17 Israel ACM 31 patients (15 with
seizures)
22 T, C, TC Yes Watch-like Sensitivity 91% (20 detected), 8 false positives
in 1692h (FDR per 24h 0.11, all during day),
median latency 17s
Lockman et al.18 US ACM 40 adult patients
(6 with seizures)
8 TC Yes Watch 7/8 (87.5%) detected of which 2 during day (1
possibly missed because of uncharged battery
or Bluetooth failure), PPV>50% (204 false
positives during day when alarm can be turned
off, 1 at night), latency to onset C phase 4–15 s
Masse´ et al.4 and
van Elmpt et al.41
Netherlands/
Belgium
ECG (integrated
ACM not used)
17 patients (10
with seizures)
104 (mostly T and M but
also absence and TC)
Yes (but not yet
in article)
Necklace or attached to
arm+electrodes on chest
HR changes in 50/104 (48%) of 8 patients,
algorithm tested on 3 patients with>10
seizures with HR changes: sensitivity>90%,
PPV>50%
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A. Van de Vel et al. / Seizure 22 (2013) 345–355350Finally, a miniature device attached to the skin of the
suprasternal notch on the neck can measure airﬂow by detecting
sound created by turbulence occurring in the human respiratory
system. Table 2 mentions such a device manufactured by the UK
company Ervitech. Although it is assumed to detect apnoea during
seizures, the only article published to date does not focus on
epilepsy.47
4.5. Detecting other autonomic changes: electrodermal activity (EDA)
Autonomic changes can affect the skin in three different ways.
Skin perfusion, manifested by ﬂushing, can be measured with
electrodes (Section 4.4). For goose bumps/piloerection, forms of
detection other than by video or self-reporting have not been
described.48 EDA, deﬁned as skin resistance or conductance, is
measured by ohm-metres or galvanometers respectively and
shows as sweating/sudomotor signs.
GTCS show an increase in autonomic discharges, particularly
sympathetic. While changes in blood pressure, HR(V), respiration
and other autonomic signs are controlled by both the parasympa-
ticus and the orthosympaticus, sweat glands are surrounded by
sympathetic ﬁbres. Modulation in EDA thus reﬂects purely
sympathetic activity and could be used for GTCS detection. One
US team has published a report on a wrist-attached device that
combines EDA and ACM in order to detect seizures. The results are
mentioned in Table 1.49
4.6. Detecting motor seizures
Movement can be detected by various methods that can serve
different purposes. Movement energy can be monitored by video
or by ACM, gyroscopes (gyro), magnetometers (magneto) or EMG
attached to the limbs. It can warn of possible trauma by hitting an
object. Attached to the trunk, ACM, gyro or magneto devices can
provide information on the position of the patient, thereby
providing warning when seizures occur in the prone position
(risk of suffocation). In combination with a humidity metre, they
could provide an alert when there is risk of inhaling vomit or other
ﬂuids in the supine position. Video or ACM devices attached to the
trunk can also detect falling or loss of balance during a seizure.
Finally, movement duration could warn of evolvement to status
epilepticus.
4.6.1. Video
Video detection is part of the gold standard for seizure
detection, and it is the only means of performing retroactive
visual evaluation of detected events. It is contactless, unless
infrared wave reﬂectors are afﬁxed to motion-relevant locations on
the patient’s body (e.g. joints or extremities).50 Video might even
be used to detect HR(V) and respiration rate (Sections 4.3.1 and
4.4).51,52
One disadvantage of video detection involves the difﬁculty of
detecting movement under blankets (although shapes on the
blanket help) or the need to sleep without a blanket when using
coloured pyjamas.53 Further, recording all aspects of a movement
requires the patient to be constantly within the scope of one or
more cameras (this is less problematic at night).
A thermal or thermographic camera detecting infrared waves
from body (movement) through blankets and clothing could also
be used. Such cameras are also assumed able to detect respiration.
Disadvantages involve the current reliability of such cameras (e.g.
the resolution is considerably inferior to that of optical cameras),
and their cost.
Teams from Belgium, Germany/Portugal and the US are
independently focusing on seizure detection using automated video
analysis. Results from these studies can be found in Table 1.50,54,554.6.2. Electromagnetic waves
Using the Doppler effect, microwaves and radio waves have
been tested for detecting movement, as well as heart rate and
respiration (Sections 4.3.1 and 4.4).56,57 Such techniques offer the
advantage of allowing contactless recording through blankets and
clothing.
Disadvantages of electromagnetic devices involve their current
reliability and the constant electromagnetic radiation exposure.
Radiation damage depends upon the wave type (some have
ionising, electrical or biological/heating effects on the human
body), intensity, cumulative exposure and exposure duration.
4.6.3. Accelerometer (ACM), gyroscope (gyro), magnetometer
(magneto) and electromyography (EMG)
ACM devices measure translational acceleration. They have a
low cost and with their low energy consumption, they enable
ambulatory monitoring with a small device. They can be used for
detecting clonic seizures.18 Gyro sensors measure angular/rota-
tional acceleration and are useful for detecting versive seizures.
Magneto sensors can determine position and orientation changes
of limbs or body and are interesting for detecting tonic seizures,
because of the ‘positioning’ that takes place in these seizures. They
are thus also useful for detecting tonic–clonic seizures because of
their capacity to detect the tonic phase early.38 Because they record
muscle signals, EMG devices are well suited for detecting tonic
seizures and the early phase of tonic–clonic seizures.58
Attached to the patient, these sensors have the advantage of
being linked directly to movement (including motor seizures) and
of being able to distinguish between the movements of individual
limbs. Attached to the bed or mattress, however, they are more
comfortable for the patient and possibly less susceptible to
dislocation over time.
Several teams from Austria, Belgium, Denmark, France, Israel,
the Netherlands, the US and US/Ireland are performing research on
movement detection using any or a combination of the methods
mentioned above. The results of their research are mentioned in
Table 1.2,14,17,18,59–65 Finally, many commercially available sys-
tems use these or other unspeciﬁed movement-detection methods.
See Table 2 and Section 5 for more information.
4.7. Detecting non-motor seizures
4.7.1. Audio
Noises that occur during seizures include stereotypical screams,
singing or humming, autonomic laughing or weeping, bronchial
secretions, lip smacking and bed noises when moving. In addition,
some audio devices can even detect respiration (Section 4.4).
The advantages of audio devices include their low cost, comfort
(contactless) and practical use. They are often based on baby-
phone systems and, to date, they are the most commonly used
system for paediatric patients.
One disadvantage of audio devices involves their generally poor
performance and detection of many false positives. One major
challenge to this technique involves the development of algo-
rithms that can suppress background noises originating from the
environment, as well as from the patient (e.g. speech or snoring). In
some cases, however, snoring can be a seizure manifestation. For
example tonic–clonic seizures are often followed by loud and
typically stertorous breathing.66
Various audio systems produced by the UK company Medpage
have undergone testing by US research teams. Results and more
information can be found in Tables 1 and 2.15,16 Table 1 also shows
research results regarding audio-based seizure detection con-
ducted by a team from the Netherlands.67 Table 2 further lists Ep-It
(Alert-It), a system that combines audio with other detection
methods, but of which no publications could be found.
Table 2
Non-EEG based alarm systems that are commercially available or under clinical trial investigation and that are speciﬁcally aimed at epilepsy and epileptic seizures. Information given as available in article or on website.
ACM=accelerometer, C = clonic seizures, ECG=electrocardiography, EMG=electromyography, EOG=electro-oculography, H=hypermotor seizures, Hz=hertz, M=myoclonic seizures, npf =no publication found with our search
strategy, PPG=photo plethysmography, S = spasms, s = seconds, T = tonic seizures, TC= tonic–clonic seizures, VNS=vagus nerve stimulation.
Company Device name Detection method Contact(less) Seizures/events Article Status Website
Alert-It (UK) Ep-It Companion
Monitor (S1029)
Unspeciﬁed movement
sensor, audio, moisture
sensor, body pressure
Under mattress (mat)
and on mattress or
under pillow sheet
TC and S, urination and
vomiting, prolonged bed
vacancy
npf On market http://www.alert-it.co.uk
Ep-It Guardian
Monitor (P139)
Unspeciﬁed movement
sensor that can also
detect respiration,
audio, moisture
sensor, body pressure
Under mattress (mat)
and on mattress or
under pillow sheet
TC, S and complex seizures,
abnormal breathing, urination
and vomiting, prolonged bed
vacancy, allows monitoring of
up to 32 patients
npf On market
BioLert (Israel) EpiLert ACM for movement Watch-like TC, T, C Kramer et al.17 FDA/CE approval
expected
http://www.biolertsys.com
Cyberonics, Inc. (US) AspireSR ECG Implanted (linked to
VNS therapy so closed-
loop)
Cardiac events during
(unspeciﬁed) seizures
npf Clinical trial recruiting http://clinicaltrials.gov/
ct2/show/NCT01325623
Danish Care (Denmark) Epi-Care Free ACM for movement Bracelet TC in adults and teenagers Beniczky et al.14 On market http://danishcare.dk/dk
Epi-Care 3000 ACM for movement Afﬁxed to mattress Convulsions such as TC, S
mainly in small children
npf On market
D.C.T. Associates Pty Ltd
(Australia)
Vigil-Aide Unspeciﬁed vibration
detection
Afﬁxed to bed or worn
in pouch/belt during
day
Convulsions npf On market http://www.dctassociates.
com.au/convul.htm
Emﬁt Ltd (Finland) Emﬁt Seizure
Monitor
ACM for movement and
respiration (even heart
beating according
website), body pressure
Under mattress mat Convulsions such as TC and S,
micro-movements caused by
breathing and heart beating,
prolonged bed vacancy
npf On market http://www.emﬁt.com
Ep Detect (UK) EpDetect Unspeciﬁed movement
sensor
Application for mobile
phone
Seizures with 2–5Hz
movements that persist 10 s
npf To be downloaded (free
of charge)
http://www.epdetect.com
Epicall Ltd (Israel) Epicall EOG, PPG Sticker placed on side
of face
Eye movements, heart rate
and pulse as pre- or early
(unspeciﬁed) seizure markers
npf Clinical trial not yet
recruiting
http://clinicaltrials.gov/
show/NCT01436695
Ervitech (UK) – Audio for respiration Placed in neck Apnea during (unspeciﬁed)
seizures
Corbishley and
Rodrı´guez-Villegas47
(not on seizures yet)
Clinical trial http://www.theengineer.
co.uk/advanced-acoustic-
monitor-detects-breathing-
difﬁculties/1004884.article
Holst Centre/imec, Hobo
Heeze BV (Netherlands)
– ECG Armband with chest
electrodes
Major epileptic seizures
such as TC, T, C, H
Masse´ et al.4 and
van Elmpt et al.41
Patent taken, clinical
trial ongoing
http://www.holstcentre.com
http://www.hoboheeze.nl
IctalCare A/S (Denmark) IctalCare 365 EMG ePatch attached to
upper arm or leg
TC Conradsen et al.58 Launch expected
beginning 2013
http://www.ictalcare.dk
Medpage (UK) MP5 Audio for movement
(bed noises) and
vocalizations
Under mattress TC in patients weighing
12.7 kg
Carlson et al.15
and Fulton et al.16
On market http://www.medpage-
ltd.com
MP2 Unspeciﬁed movement
sensor
Under mattress TC in patients weighing
12.7 kg
npf On market
ST-2 Unspeciﬁed movement
sensor (audio?) and
body pressure
Under mattress mat TC and prolonged bed vacancy
in patients weighing 12.7kg
Fulton et al.16 On market
Sensorium (UK) Sensalert (102/EP200) Unspeciﬁed movement
sensor and optional
moisture sensor
Under mattress TC, optional enuresis npf On market http://www.sensorium.co.uk
Smart Monitor Corp. (US) SmartWatch ACM for movement Watch Convulsive seizures
mainly TC, C
Lockman et al.18 FDA/CE approval
expected, clinical tri-al
ongoing
http://www.smart-monitor.
com
Vahlkamp (Netherlands) Epi-Watcher Unspeciﬁed movement
sensor
Under mattress mat TC npf On market http://www.vahlkamp.nl
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Both eyelid and ocular movements can be detected by EOG,
which is capable of differentiating epileptic seizures from syncope,
psychogenic or other non-epileptic seizures.68 Table 2 mentions
the Epicall system (Israeli company Epicall Ltd), which uses a
sticker placed on the side of the face to measure eye movements,
heart rate and pulse as pre-seizure or early seizure markers. A
clinical trial is expected.
4.7.3. Temperature
It remains to be investigated whether temperature measure-
ment can detect seizures. Although it would be an appropriate
method for detecting febrile seizures, the exact relationship of
these seizures to epilepsy is not known. Temperature changes can
be measured by thermometers that exist in the form of adhesive
stickers, and by thermal cameras that additionally could detect
movement (Section 4.6.1).
4.8. Additional detection
4.8.1. Body pressure
Pressure mats can be used to detect bed vacancy (falling or
somnambulism), although they are not designed speciﬁcally as a
method for detecting seizures. These mats should be combined
with other detection modalities, as is the case with some
commercially available seizure-detection devices, including Ep-It
(Alert-It), Emﬁt (Emﬁt Ltd) and ST-2 (Medpage) (Table 2).
4.8.2. Moisture
In addition to the measurement of sweating (Section 4.5),
humidity metres can detect some ictal symptoms, including
salivation, vomiting and incontinence. One disadvantage is that
such manifestations are not related exclusively to seizures. Some
commercial seizure-detection systems, however, including Sensa-
lert (UK company Sensorium) and Ep-It (Alert-It), make use of a
sheet with sensor wires sewn into silver in order to combine
moisture sensing with other detection methods.
5. Commercial systems
Devices for monitoring heart rate, oxygen saturation, respira-
tion and body movements are commonly used in ﬁelds other than
epilepsy, although their reliability for detecting seizures or
identifying high-risk patients has yet to be proven. Further studies
could determine whether these measures could play a role
preventing SUDEP.69
In this section (and in Table 2), the focus is on systems that are
commercially available or under clinical trial investigation and
that are speciﬁcally aimed at epilepsy and seizures. As mentioned
in Section 4, published studies are rare, and additional investiga-
tion is needed in order to provide neurologists and patients with an
objective overview of advantages, disadvantages and efﬁcacy of
these systems.
Devices that have been described in literature (last seven
listed in Table 1) include the under-mattress MP5 and ST-2 by
Medpage (UK),15,16 an electrocardiography armband with chest
electrodes by Holst Centre/imec and Hobo Heeze B.V.
(Netherlands),4,41 the electromyography-based ePatch IctalCare
365 by IctalCare A/S (Denmark),58 the Epi-Care Free bracelet by
Danish Care (Denmark),14 SmartWatch by Smart Monitor
Corporation (US)18 and the watch-like EpiLert by BioLert
(Israel).17 All but the Medpage devices can be used during
the day/outside of bed, and they have shown good results
for tonic–clonic seizures. Latency from clinical seizure onset
to detection has been mentioned for the latter three. The
majority of seizures was detected relatively late, as the devicesare based on accelerometry, thus mainly identifying the clonic
phase.
Another mobile device is the belt-worn or pouch-worn Vigil-
Aide by D.C.T. Associates Pty Ltd (Australia), which has a maximal
range of 150 metres (as compared to 20 metres for the Epi-Care
Free). Visibility (or non-visibility) is important to consider for
devices that are worn during the daytime.
Sensors attached under the mattress or bed are the most
widespread, although they often lack speciﬁcity59: They are not
mobile and are therefore used primarily for detecting nocturnal
seizures. They include MP2 by Medpage (UK), Epi-Care 3000 by
Danish Care (Denmark), Emﬁt Seizure Monitor by Emﬁt Ltd
(Finland), Sensalert (102 and EP200) by Sensorium (UK), Epi-
Watcher by Vahlkamp (Netherlands) and Ep-It (S1029 and P139)
by Alert-It (UK).
Information on the following devices is available online,
although they are not yet commercially available: the combined
electro-oculography and photo plethysmography device Epicall by
Epicall Ltd (Israel), an audio sensor for respiration monitoring by
Ervitech (UK) and a device with cardiac-based seizure detection
and responsive vagal-nerve stimulation therapy by Cyberonics,
Inc. (US).
Finally, the EpDetect software programme by Ep Detect (UK)
can be downloaded onto a mobile phone. It monitors the
movements of the wearer and alerts the caregiver of the patient’s
status in case of tonic–clonic seizures.
Some devices have additional valuable features: cancelling
alerts that are set off inadvertently (SmartWatch, EpDetect);
adjusting patient-speciﬁc parameters, including threshold for
seizure intensity (MP5, SmartWatch), seizure duration (Smart-
Watch), user weight (Sensalert), mattress type (MP5, Sensalert)
and seizure nature (Sensalert); warning with a pre-alarm buzz
(Sensalert); setting the alarm delay at different interval times
(Vigil-Aide, Emﬁt Seizure Monitor); or alerting the caregiver of the
patient’s position through an incorporated GPS (EpDetect, EpiLert,
IctalCare 365, SmartWatch).
6. Multimodal systems
Epileptic seizures have a stereotypical nature, however, seizure
manifestations vary by patient and a given patient may have
different seizure types. Detection devices may therefore be
developed based on a template using the composite features of
the various non-EEG body signals, which may serve as the
signature of a particular seizure type in an individual patient. The
template-matching method may be applied within a larger
population for various seizure types, and it may even detect
different patterns for true and pseudo-seizures.2
The advantages and disadvantages associated with each
method (Section 4) can determine which methods should be
combined and which body signals should be measured in order to
develop an efﬁcient device. It is particularly interesting to include
monitoring cardiac, respiratory or other autonomic dysfunction as
these are possible patho-physiological mechanisms of SUDEP.
Monitoring movement is important as well, as many seizures have
a motor component.
We nevertheless believe that there is a trade-off between the
number of sensors and the patient’s comfort, unless non-
contacting sensors are used. Moreover, even though non-EEG
body-signal monitoring and automated analysis might be less
complex than are those used in EEG devices, and as a consequence
use less power, it is obvious that power consumption increases
when more sensors are used, thus resulting in larger and more
expensive devices.
Some published studies, including those reported by the
teams in Denmark58,60 and France,38,59,61 have already combined
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A. Van de Vel et al. / Seizure 22 (2013) 345–355 353several methods for movement detection, and some commercial
devices even combine methods for detecting multiple body
signals.
Table 3 provides a summary of the seizure manifestations and
corresponding detection methods that have been discussed and
proposes possible combinations.
7. Discussion
The number of refractory patients, the mortality rate of epilepsy
and the many requests from patients and caregivers indicate that
there is a medical need as well as societal pressure for an optimal
seizure-detection system, as well as a clearer overview of
commercial devices that can be used for long-term and home
monitoring. In addition, those with a diagnosis that has yet to be
conﬁrmed could use such devices before seeing a neurologist.
Detection systems are also useful if only to offer reassurance to
patient and environment.
Finally, detection systems (and the logging of information) are
important in the context of SUDEP. First, these systems have been
identiﬁed as one of the key measures for preventing SUDEP,
although their protective effects require further investigation.
Detection is especially important for patients who are refractory to
treatment or those who experience only a few but dangerous
seizures. Second, detection systems can enhance the understand-
ing and deﬁnition of SUDEP-related risk factors and patho-
physiological mechanisms. They are objective and can provide
information on whether SUDEP or near-SUDEP events were
preceded by seizures. Third, when there is additional clarity
concerning risk factors and mechanisms, devices (together with
genetic and lifestyle information) could contribute by allowing
patient screening, creating risk proﬁles and identifying high-risk
patients.
The efﬁcacy and reliability of many commercial non-EEG
devices has yet to be demonstrated, and research tends to
focus more on EEG than it does on non-EEG signals. Neverthe-
less, non-EEG signals provide valuable indirect information
about the state of the brain, in many cases, they are more
directly related to seizure symptoms. Non-EEG devices are
more widely applicable than EEG devices are, as they are not
invasive and less obtrusive. Long-term home monitoring
reduces costs by eliminating the necessity of hospital admission
and clinical observation. Non-EEG detection methods allow
direct testing on humans. Finally, automated detection algo-
rithms might be less complex than are those used in EEG
devices. This should make it possible to generate an optimal
multimodal device sooner than intracerebral detection and
prediction systems.
Due to the large variety in seizures and movement patterns,
the differences between adult, paediatric and neonatal patients,
and the difﬁcult distinction between epileptic and non-epileptic
manifestations, it will probably never be possible to produce a
truly universal system. Should it prove necessary to differentiate
between various seizure types, particular emphasis should be
placed on nocturnal frontal lobe (e.g. hypermotor) and tonic–
clonic seizures. Both are risk factors for SUDEP, hypermotor
seizures are often refractory and accompanied by a high level of
morbidity (injuries), and tonic–clonic seizures can lead to status
epilepticus. In addition to seizure type, detection systems should
also consider the seizure severity and the patient’s quality of life.
It should be possible to customise devices to the user’s needs
and personal preferences (e.g. such that they would not wake
the patient and environment for situations that are not life-
threatening, unless requested). This raises issues regarding the
need to distinguish between detecting seizures and detecting
danger. 
A. Van de Vel et al. / Seizure 22 (2013) 345–3553548. Conclusion
There is an obvious need for a seizure-detection system that can
be used for long periods and in the home situation in order to
facilitate early intervention for and prevention of seizure-related
side effects, including SUDEP. Considerable research has focused
on intracerebral detection and action. Most extracerebral, non-EEG
devices are developed using only one modality for monitoring one
physiological signal.
We propose the need to develop multimodal non-EEG based
systems, and we believe that the primary focus should lie on
modalities that can monitor cardiac, respiratory or other auto-
nomic signals, as they are possible patho-physiological mecha-
nisms of SUDEP. The devices should also detect movement, as
many seizures have motor manifestations.
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